Abduh Murshed
Research Subjects
Abduh Murshed has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Bashir Ahmad
Affiliations Department of Pediatrics, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China, Department of Biology, The University of Haripur, Khyber Pakhtunkhwa, Pakistan
3 shared publications - Jun Lu
Department of Paediatrics, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
3 shared publications - Mohamed Y. Zaky
Department of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt
2 shared publications Ashraf Ali
1 shared publicationAta Ur Rehman
1 shared publicationAzizullah Azizullah
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Food Quality
- Vol. 2026 (1)
Phytochemical and Pharmacological Insights Into Ranunculus hirtellus Royle: An Animal’s Fodder Plant
Background: Ranunculus hirtellus Royle, a perennial herb belonging to the Ranunculaceae family, is native to the Himalayan region and widely used in traditional medicine. The plant is valued for its diverse applications as an anthelmintic, cooling agent, wound healer, livestock feed, and for managing gout, reproductive disorders, and skin conditions. Despite its considerable ethnobotanical importance, a comprehensive review of its traditional uses and pharmacological properties is still lacking. Aim of the Study: This study aims to systematically review the available literature on the ethnobotanical, phytochemical, and pharmacological properties of R . hirtellus , thereby providing a foundation for future pharmacological and experimental research. Materials and Methods: A comprehensive literature search was conducted using databases such as Google Scholar and PubMed to identify studies related to the ethnobotanical, phytochemical, and pharmacological aspects of R . hirtellus . The review focused on its traditional uses, bioactive compounds, and experimentally validated biological activities. Results: R . hirtellus contains various phytochemicals, including flavonoids, steroids, glycosides, quinones, lactones, and lignified fibers. It exhibits diverse pharmacological activities, including antioxidant, antidiabetic, antibacterial, antifungal, anthelmintic, antiaging, antigout, anti‐irritant, and wound healing properties. In addition, it is used as livestock feed, a cooling agent, and for treating reproductive disorders. Preliminary evidence suggests its potential for anticancer, anti‐inflammatory, neuroprotective, and antiasthmatic effects, which remain underexplored. Conclusion: This review consolidates the traditional and pharmacological knowledge of R . hirtellus , highlighting its biomedical potential. Further computational and experimental studies are warranted to validate its therapeutic properties and explore its unexplored pharmacological activities.
- 1 January 2026
- Published by Wiley in Journal of Food Quality
- Vol. 2026 (1)
Open AccessPhytochemical and Pharmacological Insights Into Ranunculus hirtellus Royle: An Animal’s Fodder Plant
Background: Ranunculus hirtellus Royle, a perennial herb belonging to the Ranunculaceae family, is native to the Himalayan region and widely used in traditional medicine. The plant is valued for its diverse applications as an anthelmintic, cooling agent, wound healer, livestock feed, and for managing gout, reproductive disorders, and skin conditions. Despite its considerable ethnobotanical importance, a comprehensive review of its traditional uses and pharmacological properties is still lacking. Aim of the Study: This study aims to systematically review the available literature on the ethnobotanical, phytochemical, and pharmacological properties of R . hirtellus , thereby providing a foundation for future pharmacological and experimental research. Materials and Methods: A comprehensive literature search was conducted using databases such as Google Scholar and PubMed to identify studies related to the ethnobotanical, phytochemical, and pharmacological aspects of R . hirtellus . The review focused on its traditional uses, bioactive compounds, and experimentally validated biological activities. Results: R . hirtellus contains various phytochemicals, including flavonoids, steroids, glycosides, quinones, lactones, and lignified fibers. It exhibits diverse pharmacological activities, including antioxidant, antidiabetic, antibacterial, antifungal, anthelmintic, antiaging, antigout, anti‐irritant, and wound healing properties. In addition, it is used as livestock feed, a cooling agent, and for treating reproductive disorders. Preliminary evidence suggests its potential for anticancer, anti‐inflammatory, neuroprotective, and antiasthmatic effects, which remain underexplored. Conclusion: This review consolidates the traditional and pharmacological knowledge of R . hirtellus , highlighting its biomedical potential. Further computational and experimental studies are warranted to validate its therapeutic properties and explore its unexplored pharmacological activities.
- Open Access
- 1 January 2024
- Published by Wiley in Journal of Food Quality
- Vol. 2024 (1)
Phytochemical Profiling and Therapeutic Potential of Abelmoschus esculentus Fruit Extracts: Insights Into Antidiabetic Potential in In Vitro and In Vivo Experiments
Due to inadequate treatment, diabetes mellitus, which is characterized by hyperglycemia, is a global health challenge that requires creative management techniques. This study explores the therapeutic potential of Abelmoschus esculentus L. Moench fruit extracts in diabetes, offering an ample approach includes phytochemical analysis, qualitative and quantitative assessments, antidiabetic efficacy, antioxidant potential, and in vivo and in vitro investigations. Thin‐layer chromatography (TLC), high‐performance liquid chromatography (HPLC), and gas chromatography–mass spectrometry (GC–MS) were utilized to disclose the phytochemical profile of the fruit extracts, which indicated a diverse range of bioactive compounds. Four polyphenolic compounds including chlorogenic acid, quercetin, rutin, and morin were confirmed by HPLC fingerprinting, with rutin being the most prevalent. Qualitative analysis reveals the presence of carbohydrates, emodin, terpenoids, lignin, glycosides, and anthraquinones, while indicating the absence of amino acids, anthocyanins, phlobatannins, lactones, and leucoanthocyanins. Quantitative analysis reveals total phenolic, tannin, and flavonoid. In vitro assessments demonstrate the ability of the extracts to inhibit alpha amylase. Radical scavenging activities were evaluated through DPPH assay, underscoring their antioxidant capacity with high effect in methanol extracts. Additionally, the methanol extract decreased the blood glucose level of Type 2 diabetic mice. Notably, test samples stabilized blood glucose levels, reversed deviations in blood profile parameters, blood biochemistry, and regulated organ weight. Based on its antioxidant and antidiabetic effects, as well as positive effects on the physiology of Type 2 diabetic mice, A. esculentus emerges as an important nutraceutical vegetable. As an important nutraceutical vegetable, it holds promise for diabetes management. A. esculentus can be incorporated into dietary interventions for individuals with diabetes, harnessing its natural antioxidant and antidiabetic properties. Our findings validate the traditional use of A. esculentus in green therapeutics. In conclusion, A. esculentus emerges as a valuable ally in the fight against diabetes, bridging the gap between ancient wisdom and modern science. Further research and practical implementation are warranted to fully realize its potential.
- 1 January 2024
- Published by Wiley in Journal of Food Quality
- Vol. 2024 (1)
Open AccessPhytochemical Profiling and Therapeutic Potential of Abelmoschus esculentus Fruit Extracts: Insights Into Antidiabetic Potential in In Vitro and In Vivo Experiments
Due to inadequate treatment, diabetes mellitus, which is characterized by hyperglycemia, is a global health challenge that requires creative management techniques. This study explores the therapeutic potential of Abelmoschus esculentus L. Moench fruit extracts in diabetes, offering an ample approach includes phytochemical analysis, qualitative and quantitative assessments, antidiabetic efficacy, antioxidant potential, and in vivo and in vitro investigations. Thin‐layer chromatography (TLC), high‐performance liquid chromatography (HPLC), and gas chromatography–mass spectrometry (GC–MS) were utilized to disclose the phytochemical profile of the fruit extracts, which indicated a diverse range of bioactive compounds. Four polyphenolic compounds including chlorogenic acid, quercetin, rutin, and morin were confirmed by HPLC fingerprinting, with rutin being the most prevalent. Qualitative analysis reveals the presence of carbohydrates, emodin, terpenoids, lignin, glycosides, and anthraquinones, while indicating the absence of amino acids, anthocyanins, phlobatannins, lactones, and leucoanthocyanins. Quantitative analysis reveals total phenolic, tannin, and flavonoid. In vitro assessments demonstrate the ability of the extracts to inhibit alpha amylase. Radical scavenging activities were evaluated through DPPH assay, underscoring their antioxidant capacity with high effect in methanol extracts. Additionally, the methanol extract decreased the blood glucose level of Type 2 diabetic mice. Notably, test samples stabilized blood glucose levels, reversed deviations in blood profile parameters, blood biochemistry, and regulated organ weight. Based on its antioxidant and antidiabetic effects, as well as positive effects on the physiology of Type 2 diabetic mice, A. esculentus emerges as an important nutraceutical vegetable. As an important nutraceutical vegetable, it holds promise for diabetes management. A. esculentus can be incorporated into dietary interventions for individuals with diabetes, harnessing its natural antioxidant and antidiabetic properties. Our findings validate the traditional use of A. esculentus in green therapeutics. In conclusion, A. esculentus emerges as a valuable ally in the fight against diabetes, bridging the gap between ancient wisdom and modern science. Further research and practical implementation are warranted to fully realize its potential.
- Open Access
- 1 January 2024
- Published by Wiley in Journal of Food Quality
- Vol. 2024 (1)
Berberis lycium: A Miracle Medicinal Plant with Multifaceted Health Benefits
Throughout history, medicinal plants have been used to treat different ailments. About 70 to 80% of the world population rely on medicinal plants for healthcare and some use it for income generation. The annual sale of medicinal plants increases over time. In plants, Berberis vulgaris f. lycium (Royle) Parsa (Berberis lycium), also called boxthoran barberry, Indian barberry, or Indian lyceum contains key alkaloids such as berberine, camptothecin, koumidine, salutaridine, luteanine, palmatine, and protopine. Significant steroidal compounds include sitosterol and B‐sitosterol. The plant is rich in flavonoids such as isorhamnetin, formononetin‐7‐O‐glucoside, and velutin and anthocyanins such as cyanidin‐3‐glucoside and delphinidin‐3‐glucoside. It also includes phenolic compounds such as chlorogenic acid, caffeic acid, vanillic acid, and quercetin. B. lycium possesses dual utility due to its delicious fruit and has high value with known history in treatment of different disease and use in folklore medicines. Ethnobotanical surveys reveal that the B. lycium is used to treat jaundice, hepatitis, typhoid, fever, tuberculosis disorders, eye lotion, chronic diarrhoea, tonic, skin diseases, blood purifier, piles, eye infections, gum problems, diabetes, and kidney problems. Experimental studies have demonstrated that the B. lycium possesses antibacterial, antihyperlipidaemia, antidiabetic, anticolitis/inflammatory, anticancer activities, antiviral activities, and anthelminthic activities. According to our literature survey, there is no review with a mechanistic summary on B. lycium; therefore, the current review is an effort to provide the available literature on B. lycium in summary form for future research.
- 1 January 2024
- Published by Wiley in Journal of Food Quality
- Vol. 2024 (1)
Open AccessBerberis lycium: A Miracle Medicinal Plant with Multifaceted Health Benefits
Throughout history, medicinal plants have been used to treat different ailments. About 70 to 80% of the world population rely on medicinal plants for healthcare and some use it for income generation. The annual sale of medicinal plants increases over time. In plants, Berberis vulgaris f. lycium (Royle) Parsa (Berberis lycium), also called boxthoran barberry, Indian barberry, or Indian lyceum contains key alkaloids such as berberine, camptothecin, koumidine, salutaridine, luteanine, palmatine, and protopine. Significant steroidal compounds include sitosterol and B‐sitosterol. The plant is rich in flavonoids such as isorhamnetin, formononetin‐7‐O‐glucoside, and velutin and anthocyanins such as cyanidin‐3‐glucoside and delphinidin‐3‐glucoside. It also includes phenolic compounds such as chlorogenic acid, caffeic acid, vanillic acid, and quercetin. B. lycium possesses dual utility due to its delicious fruit and has high value with known history in treatment of different disease and use in folklore medicines. Ethnobotanical surveys reveal that the B. lycium is used to treat jaundice, hepatitis, typhoid, fever, tuberculosis disorders, eye lotion, chronic diarrhoea, tonic, skin diseases, blood purifier, piles, eye infections, gum problems, diabetes, and kidney problems. Experimental studies have demonstrated that the B. lycium possesses antibacterial, antihyperlipidaemia, antidiabetic, anticolitis/inflammatory, anticancer activities, antiviral activities, and anthelminthic activities. According to our literature survey, there is no review with a mechanistic summary on B. lycium; therefore, the current review is an effort to provide the available literature on B. lycium in summary form for future research.